## 



## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 



## 

## 

## 



## 

|||FOR T|HE YEAR ENDE|D 31JANUARY 20|21||
|---|---|---|---|---|---|---|
|||||Unrestricted|Year to|Year to|
||||||Jan|Jan|
|||||Funds|2021|~20 0|
||||Notes|E|F||
|Income and endowments||from|||||
|Donations<br>&legacies<br>Charitable<br>activities<br>Investments||||29,600<br>61,220<br>11|29,600<br>61,220<br>11|21,200<br>46,919<br>25|
|Total Income||||90,831|90,831|68,144|
|Expenditure<br>on:|||||||
|Charitable<br>activities||||66,165|66,165|67,196|
|Total Expenditure||||66,165|66,165|67,196|
|Net Income||||24,666|24,666||
|Transfers<br>between|funds||||||
|Net outgoing<br>resources before other||||24,666|24,666|948|
|recognised<br>gains and losses|||||||
|Net movement<br>in funds||||24,666|24,666|948|
|Reconciliation<br>of|||||||
|Funds:|||||||
|Total funds brought|forward|||50,464|50,464|49,516|
|Total Funds carried forward||||75,130|75,130|50,464|
|All ofthe results derive from||continuing|activities.||||





## 

## 


## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

|Grants||||
|---|---|---|---|
|Althea Company<br>Camurus<br>Ltd||10,500<br>14,000|4,000<br>10,200|
|Ethypharm|UK Ltd|5,100|700|
|||29,600|14,900|



## 

## 

|INCOMEFROM|||
|---|---|---|
|CHARITABLE ACTIVITIES|2021|2020|
|Membership|49,015|29,424|
|Conference<br>&training|10,855|13,375|
|Other income|1,350|4,120|
||61,220|46,919|



## 

## 

|EXPENDIT<br>RE<br>||||
|---|---|---|---|
|N CHARITABLE ACT|ITES|2021|2020|
|External advisory<br>&supervision<br>work<br>Website, newsletter<br>&publicity<br>Conference<br>and training<br>activities||55,253<br>7,538<br>10|45,39?<br>14,412<br>132|
|Travel &general<br>administration<br>costs<br>Accountancy<br>&professional<br>fees<br>Independent<br>Examiners Fees||161<br>1,591<br>960|1,288<br>4,027<br>960|
|Other costs||652|980|
|||66,165|67,196|





## 

## 

## 

|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|10.|DEBTORS||||||||2021||2020|
||Amounts<br>falling due within one year:|||||||||||
||FDAP Outstanding||||||||||11,285|
||Addiction<br>Professionals|||Ltd outstanding|||||785||6,000|
||||||||||785||17,285|
|11.|/RED~IT<br>R'j||||||||2021||2020|
||Amounts<br>falling due within one year:|||||||||||
||Trade creditors and||accruals||||||4,615||2,760|
||||||||||4,615||2,760|
|12.|UNRESTRICED|FUNDS||||||||||
||Year ended 31Janua|||2021|Balance at<br>01/02/2020||Incoming<br>Resources||Outgoing<br>Resources|Balance at<br>01/02/2021||
||General funds|||||50,464||90,831|(66,165)||75,130|
||Total funds|||||50464||90831|~66,165||75 130|
|13.|NRE TRICE|F|ND|||||||||
||Yea ended 31|anua||2020|Balance at<br>~01/ 2/2019||Incoming<br>~Resource||Outgoing<br>aesourcss|Balance at<br>~01/0<br>020||
||General funds|||||49,516||68,144|(67,196)||50,464|
||Total funds|||||49516||68 144|~67,196/||50464|
||Name offund|||Descri|tion|nature and|u|oses ofthe fund||||





## 

|||||nrestricted|
|---|---|---|---|---|
|Year ended 31||anua|2021|funds|
|Current|Assets|||79,745|
|Current|Liabilities|||~4,615|
|||||75,130|
|||||Unrestricted|
|Year ended 31 Janua|||2020|funds|
|Current <br>Current|Assets<br>Liabilities|||53,224<br>~2,760|
|||||50,464|



##